Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data

Fig. 1

Patient disposition. Abbreviations: GIST, gastrointestinal stromal tumor; PDGFRA, platelet-derived growth factor receptor A; TKI, tyrosine kinase inhibitor. aEnrollment at the data cutoff of November 16, 2018. bThe D842V population included all patients with PDGFRA D842V mutations from part 1 and part 2. cAll patients were treated with an approved treatment for GIST or investigational TKI, with initial treatment administered between January 1, 2000, and July 1, 2016

Back to article page